학술논문
Evaluation of the Xpert MTB Host Response assay for the triage of patients with presumed pulmonary tuberculosis: a prospective diagnostic accuracy study in Viet Nam, India, the Philippines, Uganda, and South Africa
Document Type
article
Author
Gupta-Wright, Ankur; Ha, Huy; Abdulgadar, Shima; Crowder, Rebecca; Emmanuel, Jerusha; Mukwatamundu, Job; Marcelo, Danaida; Phillips, Patrick PJ; Christopher, Devasahayam Jesudas; Nhung, Nguyen Viet; Theron, Grant; Yu, Charles; Nahid, Payam; Cattamanchi, Adithya; Worodria, William; Denkinger, Claudia M; Network, R2D2 TB; Thangakunam, Balamugesh; Shankar, Deepa; Ernest, Vinita; John, Flavita; Karthikeyan, Bharath; Sekar, Reena; Mangal, Divya; Vijayasree, Sai; Sankar, Swetha; Shibiya, Mary; Gajendran, Priyadarshini; Elango, Shanmugasundaram; Sekar, Rajasekar; Almonte, Jared; Basilio, Ramon; Cariaga, Asella Ruvijean; Destura, Raul; Dalay, Victoria; Dayawon, Karlo; Gelina, Darecil; Goleña, Joseph Aldwin; Golla, Maria Marissa; Ilagan, Gidalthi Jonathan; Lim, Dodge; Pabruada, Angelita; Reyes, Annalyn; Reyes, Roeus Vincent Arjay G; Tonquin, Maricef; Derendinger, Brigitta; Hendrikse, Megan; Okunola, Anna; Palmer, Zaida; Andama, Alfred; Kisakye, Esther; Mwebe, Sandra; Nakaye, Martha; Nyawere, Justine; Bukirwa, Alice; Mangeni, Wilson; Ssonko, John Baptist; Nakaweesa, Annet; Nassuna, Irene; Nekesa, Irene; Katumba, David; Asege, Lucy; Nalugwa, Talemwa; Dang, Hai; Dinh, Luong; Doan, Thien; Do, Hang; Do, Tam; Le, Hien; Le, Nguyet; Nguyen, Anh; Nguyen, Dong; Nguyen, Hanh; Nguyen, Hoang; Nguyen, Thanh; Pham, Nam; Pham, Thuong; Phan, Ha; Trinh, Trang; Castro, Robert; Cook, Catherine; Mochizuki, Tessa; Kato-Maeda, Midori; Nathavitharana, Ruvandhi; Nolan, Kevin; Olaru, Ioana-Diana; del Mar Castro Noriega, Maria; Yerlikaya, Seda
Source
The Lancet Global Health. 12(2)
Subject
Language
Abstract
BackgroundNon-sputum-based triage tests for tuberculosis are a priority for ending tuberculosis. We aimed to evaluate the diagnostic accuracy of the late-prototype Xpert MTB Host Response (Xpert HR) blood-based assay.MethodsWe conducted a prospective diagnostic accuracy study among outpatients with presumed tuberculosis in outpatient clinics in Viet Nam, India, the Philippines, Uganda, and South Africa. Eligible participants were aged 18 years or older and reported cough lasting at least 2 weeks. We excluded those receiving tuberculosis treatment in the preceding 12 months and those who were unwilling to consent. Xpert HR was performed on capillary or venous blood. Reference standard testing included sputum Xpert MTB/RIF Ultra and mycobacterial culture. We performed receiver operating characteristic (ROC) analysis to identify the optimal cutoff value for the Xpert HR to achieve the target sensitivity of 90% or more while maximising specificity, then calculated diagnostic accuracy using this cutoff value. This study was prospectively registered with ClinicalTrials.gov, NCT04923958.FindingsBetween July 13, 2021, and Aug 15, 2022, 2046 adults with at least 2 weeks of cough were identified, of whom 1499 adults (686 [45·8%] females and 813 [54·2%] males) had valid Xpert HR and reference standard results. 329 (21·9%) had microbiologically confirmed tuberculosis. Xpert HR had an area under the ROC curve of 0·89 (95% CI 0·86-0·91). The optimal cutoff value was less than or equal to -1·25, giving a sensitivity of 90·3% (95% CI 86·5-93·3; 297 of 329) and a specificity of 62·6% (95% CI 59·7-65·3; 732 of 1170). Sensitivity was similar across countries, by sex, and by subgroups, although specificity was lower in people living with HIV (45·1%, 95% CI 37·8-52·6) than in those not living with HIV (65·9%, 62·8-68·8; difference of 20·8%, 95% CI 13·0-28·6; p